Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 20003032)

1.

Low levels of high-density lipoprotein cholesterol: an independent risk factor for late adverse cardiovascular events in renal transplant recipients.

Barn K, Laftavi M, Pierce D, Ying C, Boden WE, Pankewycz O.

Transpl Int. 2010 Jun;23(6):574-9. doi: 10.1111/j.1432-2277.2009.01021.x. Epub 2009 Dec 14.

PMID:
20003032
2.

[Atherosclerosis: cholesterol efflux capacity: a new independent risk factor].

Parhofer KG.

Dtsch Med Wochenschr. 2015 Mar;140(5):309. doi: 10.1055/s-0041-100598. Epub 2015 Mar 3. German. No abstract available.

PMID:
25734667
3.

Contribution of impaired renal function to cardiovascular risk prediction models in renal transplant recipients.

Benguzzi M, Mansell H, Hassan A, Elmoselhi H, Mainra R, Shoker A.

Clin Transplant. 2014 Dec;28(12):1383-92. doi: 10.1111/ctr.12466. Epub 2014 Oct 25.

PMID:
25251543
4.

Epicardial Fat Tissue Predicts Increased Long-Term Major Adverse Cardiac Event in Patients With Moderate Cardiovascular Risk.

Ulucan S, Kaya Z, Efe D, Keser A, Katlandur H, Aygun F, Ulgen MS, Avci A, Calapkorur B, Kaya MG.

Angiology. 2014 Aug 26. pii: 0003319714548211. [Epub ahead of print]

PMID:
25163773
5.

Restoration of renal function does not correct impairment of uremic HDL properties.

Kopecky C, Haidinger M, Birner-Grünberger R, Darnhofer B, Kaltenecker CC, Marsche G, Holzer M, Weichhart T, Antlanger M, Kovarik JJ, Werzowa J, Hecking M, Säemann MD.

J Am Soc Nephrol. 2015 Mar;26(3):565-75. doi: 10.1681/ASN.2013111219. Epub 2014 Jul 28.

PMID:
25071090
6.

Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.

Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, Karaman M, Oguz Y, Eyileten T, Vural A, Covic A, Goldsmith D, Turak O, Yilmaz MI.

Int Urol Nephrol. 2014 Aug;46(8):1619-25. doi: 10.1007/s11255-014-0730-1. Epub 2014 May 23.

PMID:
24853998
7.

Progression of alterations in lipid metabolism in kidney transplant recipients over 5 years of follow-up.

Castillo RF, García Rios MD, Peña Amaro P, García García I.

Int J Clin Pract. 2014 Sep;68(9):1141-6. doi: 10.1111/ijcp.12465. Epub 2014 May 23.

PMID:
24852888
8.

High-density lipoprotein cholesterol and risk of cardiovascular events in octogenarian patients with acute coronary syndrome: long-term follow-up study.

Xue H, Fu Z, Zhu H, Chen Y, Liu H, Xin Q, Chen L, Liu J, Zhang W, Zhang S.

Int J Cardiol. 2014 Jun 1;174(1):133-4. doi: 10.1016/j.ijcard.2014.03.106. Epub 2014 Mar 21. No abstract available.

PMID:
24745859
9.

Chronic kidney disease - different role for HDL?

Jacek R, Anna G, Danilo F, Timo S, Andrzej W.

Curr Med Chem. 2014;21(25):2910-6.

PMID:
24735361
10.

Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Moradi H, Streja E, Kashyap ML, Vaziri ND, Fonarow GC, Kalantar-Zadeh K.

Nephrol Dial Transplant. 2014 Aug;29(8):1554-62. doi: 10.1093/ndt/gfu022. Epub 2014 Feb 25.

PMID:
24574544
11.

Dysfunctional HDL takes its toll in chronic kidney disease.

Moore KJ, Fisher EA.

Immunity. 2013 Apr 18;38(4):628-30. doi: 10.1016/j.immuni.2013.03.006.

12.

The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials.

Soveri I, Snyder J, Holdaas H, Holme I, Jardine AG, L'Italien GJ, Fellström B.

Transplantation. 2013 Jan 15;95(1):142-7. doi: 10.1097/TP.0b013e31827722c9.

PMID:
23192156
13.

Cardiovascular risk estimated in renal transplant recipients with the Framingham score.

de Pádua Netto MV, Bonfim TC, Costa EN, de Lima HV, Netto LC.

Transplant Proc. 2012 Oct;44(8):2337-40. doi: 10.1016/j.transproceed.2012.07.054.

PMID:
23026587
14.

Re: risk factors profile and cardiovascular events in solid organ transplant recipients.

Einollahi B, Rostami Z.

Iran J Kidney Dis. 2012 Sep;6(5):390-1. No abstract available.

15.

Re: risk factors profile and cardiovascular events in solid organ transplant recipients.

Einollahi B, Rostami Z.

Iran J Kidney Dis. 2012 May;6(3):225-6. No abstract available.

16.

Endogenous plasma erythropoietin, cardiovascular mortality and all-cause mortality in renal transplant recipients.

Sinkeler SJ, Zelle DM, Homan van der Heide JJ, Gans RO, Navis G, Bakker SJ.

Am J Transplant. 2012 Feb;12(2):485-91. doi: 10.1111/j.1600-6143.2011.03825.x. Epub 2011 Nov 4. Erratum in: Am J Transplant. 2012 Mar;12(3):797.

17.

Prevalence of modifiable cardiovascular risk factors in long-term renal transplant patients.

Vivek V, Bhandari S.

Int J Nephrol Renovasc Dis. 2010;3:175-82. doi: 10.2147/IJNRD.S13866. Epub 2010 Dec 9.

18.

Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman.

Al-Zakwani I, Sulaiman K, Al-Rasadi K, Mikhailidis DP.

Curr Med Res Opin. 2011 Apr;27(4):879-85. doi: 10.1185/03007995.2011.559537. Epub 2011 Feb 18.

PMID:
21332274
19.

South Asian ethnicity as a risk factor for major adverse cardiovascular events after renal transplantation.

Prasad GV, Vangala SK, Silver SA, Wong SC, Huang M, Rapi L, Nash MM, Zaltzman JS.

Clin J Am Soc Nephrol. 2011 Jan;6(1):204-11. doi: 10.2215/CJN.03100410. Epub 2010 Sep 30.

20.

Invited commentary on low high-density lipoprotein is a risk for vascular disease.

Kiangkitiwan B, Haririan A.

Transpl Int. 2010 Jun;23(6):571-3. doi: 10.1111/j.1432-2277.2009.01036.x. No abstract available.

PMID:
20565701
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk